Mentor Plots Cosmetic Change

The prospective reshaping of the cosmetic-medicine sector had already created plenty of drama in recent days, but now there's a new wrinkle in what has become a four-player saga.

On Sunday, Mentor (MNT Quote) made things a little more interesting, offering $2.2 billion for Medicis Pharmaceutical (MRX Quote). Upon learning of the proposal, Medicis' board members immediately rejected it and reaffirmed their own desire to continue pursuing Inamed (IMDC Quote).

Meanwhile, Inamed, Mentor's main rival in the field of breast implants, is being sought by Allergan (AGN Quote), whose bid Inamed's board seemed happy to receive last week. ...